INTRODUCTION
The fundamental reasons and test systems available for the empiric;. screening of antiviral substances was discussed by Herrmann in his review published some 15 years ago.' Today there are a number of in vitro procedures available to investigators interested in antiviral chemotherapy. Herrmann and coworkers described an agar diffusion method for the detection and bioassay of antiviral substances.2 Plastic panels frequently are used for determining the cytotoxicity and antiviral efficacy of candidate c o m p~u n d s .~*~ A mathematical treatment of data derived from panel procedures yields a "virus rating" (VR). The VR is a measure of the inhibition of the virus cytopathogenic effect by a drug at levels nontoxic or partially toxic for the host cell. In an attempt to measure the selective inhibition of viral nucleic acid synthesis compared with host nucleic acid synthesis, Miller and associatess developed a procedure utilizing the uptake of radioisotopically labeled uridine or thymidine as a criterion for antiviral activity. Although each of the above procedures has been successfully employed in antiviral screening studies, they have not been able to uniformly predict the clinical usefulness of putative antiviral drugs.
In previous studies on the biochemical action of the antiviral drug 9-8-Darabinofuranosyladenine (ara-A),e-7 we noted that herpes simplex virus (HSV) DNA synthesis was inhibited to a greater degree by the drug than was host DNA synthesis.
It is possible that the ability of ara-A to preferentially inhibit viral DNA synthesis may be related to the drug's favorable therapeutic index in experimental animals8 and man.@ Therefore, we have developed an evaluation procedure to quantitate the selective activity of ara-A and have applied it to the evaluation of other potentially useful compounds. The procedure can be used advantageously with human herpesviruses and involves the mathematical determination of a value that we have termed the "selective index" (SI). The S I is derived from a measurement of the effects of a drug on host and viral DNA synthesis by comparing 50% inhibitory (Iso) concentrations. A drug will have a positive SI if it inhibits viral DNA synthesis to a greater extent than host DNA synthesis. Conversely, a drug that inhibits host DNA synthesis more than viral DNA synthesis will have a negative SI.
MATERIALS AND METHODS

Materials
The following drugs were obtained through the courtesy of the corresponding investigators: 9-~-~-arabinofuranosyladenine (ara-A, Vira-A@), Dr. H. E. Machamer, Parke. Davis and Co., Detroit, Mich.; 1-P-D-arabinofuranosylcytosine (ara-C, Cytosar'"), Dr. H. E. Renis, The Upjohn Co., Kalamazoo, Mich.; coformycin, Dr. H. Umezawa, Institute of Microhial Chemistry, Tokyo, Japan; stallimycin (formerly Distamycin A), Dr. J. A. Page, Adria Laboratories, Inc., Wilmington, Del.; phosphonoacetic acid (PAA), Dr. R. G. Duff, Abbott Laboratories, North Chicago, Ill.: and ribavirin (VirazoleR ), Dr. R. W. Sidwell, ICN Nucleic Acid Research Institute, Irvine, Calif. The following materials were purchased from the indicated sources: 9-P-~-arabinofuranosylhypoxanthine (ara-H), Pfanstiehl Laboratories, Inc., Waukegan, 111.; 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid (HEPES) and pronase, Calbiochem, La Jolla, Calif.: sarkosyl, Geigy Industrial Chemicals, Chicago, Ill.; [m~rhyI-~HHj-thymidine (dThd) , New England Nuclear, Boston, Mass.; and CsCI, Kawecki Berylco Industries, Inc., Boyertown, Pa.
Cell Culture Terhniques
The source of cells and HSV Type I, the routine growth and passage of BHK 21/4 cells and KB cells, the propagation and titration of HSV, and the techniques used for the enumeration of cells, the determination of cell viability, and the detection of mycoplasma contamination have been described previously.fi
Protocol for Studies in Monolayer Cultures
K B cells were planted in plastic tissue culture flasks (75 cm2 surface area) (Falcon Plastics, Oxnard, Calif.) 18 to 24 hr prior to infection with HSV. At theonset of experiments, logarithmically growing, replicate monolayer cultures were 60% to 70% confluent and contained 4 to 6 x 10' cells/flask. The medium was decanted and the cultures were infected with 10 plaque-forming units (PFU) of HSV per cell. The HSV was contained in 1.0 ml of minimal essential medium with Hanks salts [MEM(H)] supplemented with 10% unheated calf serum. Mock-infected monolayer cultures received I .O ml of medium alone. After a I-hr adsorption period at 37". the cell sheet was rinsed twice with 5 ml of MEM(H) to remove unadsorbed virus and 10.0 m1 of medium containing [3H]thymidine (dThd, 5 fiM, 2 or 3 pCi/ml), 2X arginine, and 10% extensively heated calf serum* was added. Drugs were added to the medium at the selected concentrations immediately prior to use. Following a I2-or 16-hrt incubation at 37", 0.5 ml of 0.25 mM ethylenediaminetetraacetate(EDTA) was added to uninfected monolayer cultures and after several minutes at 37" flasks were shaken to suspend the cells. Infected monolayers were shaken to suspend the cells and 1.0 ml aliquots were removed and stored at -76" for subsequent virus assay. EDTA (0.45 ml) was added to the remaining medium to bring the final concentration to that in the uninfected cultures. Aliquots (100 PI) of the suspensions were spotted in triplicate on filter paper circles, which were processed for the determination of incorporated label as described previously.'j Data were tabulated on the basis of tritium incorporated into acid-insoluble material per lo5 cells. Inhibition of DNA synthesis was determined at the various drug levels as a percent of a control without drugs. Five-ml aliquots of infected cell suspensions were centrifuged at 600g for 5 min and the pellets stored at -76" for subsequent separation of viral and cellular DNA. Following isopycnic centrifugation in CsCl gradients6 the amount of tPrevious work in our laboratory6,' established that the synthesisofviral DNA was complete and drug effects were maximal 10-12 hr postinfection. label was proportioned between viral and cellular DNA on the basis of peak areas. Areas were determined directly or by integration after the peaks were fully separated using a Dupont 310 curve resolver set to fit Lorentzian distribution curves.
Statistical Analyses
Dose-response relationships were constructed by linearly regressing probit values of the percent inhibition of DNA synthesis or plaque formation against log drug concentrations. The 50% inhibitory (I5") concentrations and the 95% confidence intervals were calculated from the regression lines using the methods described by Goldstein.'" Identity of any two dose-response curves was tested by calculating p values for the equality of the regressions and slopes." Unless otherwise noted, the slopes of all the pairs of dose-response curves compared in this study were similar (p > 0.350);
consequently p values given in the text refer only to the comparison of regressions.
RESULTS
Inhibition of Total DNA Synthesis
Incorporation of labeled dThd into acid-insoluble material was determined in the presence and absence of drugs. Incorporation of label was taken as measure of the total amount of DNA synthesized by uninfected and HSV-infected monolayer cultures of KB cells. FIGURE l illustrates the inhibition of total DNA synthesis in uninfected and infected cells by ara-C and ara-A plus 3.5 pM coformycin.1 Ara-C inhibited total DNA synthesis in uninfected cells more effectively than it inhibited DNA synthesis in HSV-infected cells. This was observed a t all drug concentrations tested in three separate experiments. Construction of dose-response relationships using all values from these experiments (FIGURE 1) showed the degree of inhibition to be significantly different (p < 0.OOOl) in infected and uninfected cells. Interpolation of 50% inhibitory (I,") concentrations from these lines (FIGURE I, TABLE I ) indicated that DNA synthesis in uninfected cells was inhibited more than three times as effectively. In contrast, no consistent differences were observed in five experiments on the effects of ara-A plus coformycin on total DNA synthesis. Analysis of the overall dose-response relationships (FIGURE I ) confirmed that the drug effect was virtually the same (p = 0.41) in uninfected and HSV-infected cells. Fifty percent inhibitory concentrations also were virtually identical for uninfected and infected cells with a complete overlap of the corresponding 95% confidence intervals (FIGURE 1, TABLE I). We previously have shown that ara-H also inhibited total DNA synthesis to the same extent (p = 0.69) in uninfected and HSV-infected KB cells.' Ara-A without an adenosine deaminase inhibitor, however, was two times more effective in inhibiting total DNA synthesis in HSV-infected cells (TABLE 1) ; the two dose-response curves were parallel but not coincident (p = 0.015). ' Several other drugs have been examined in the same manner. response curves used to calculate these concentrations were not significantly different (p = 0.25 and 0.13, respectively). Like ara-C, ribavirin was more potent (10-fold) in uninfected K B cells than in HSV-infected cells. The two dose-response curves were parallel but separate (p < 0.0001).
Inhibition of D N A Synthesis in HSV-Infected C e h
Lysates were prepared from all HSV-infected cultures and were subjected to isopycnic centrifugation in CsCl gradients to separate cellular and viral DNA. The effects of ara-A plus 3.5 pM coformycin (panel A ) and ara-C (panel 9) on the amount of [3H]dThd incorporated during 12 hr of labeling are shown in Figure 2 . As is evident from the figure, viral DNA synthesis was inhibited to a significantly greater extent than was cellular DNA synthesis by ara-A plus 3.5 pM coformycin. In contrast, ara-C inhibited the synthesis of both DNA species to approximately the same extent. The data from five ara-A and three ara-C replicate experiments are summarized as doseresponse curves in FIGURE 3. Ara-A plus 3.5 pM coformycin inhibited viral DNA synthesis three times more effectively than it inhibited cellular DNA synthesis based upon the difference in the dose-response curves (p < 0.OOOl) and the difference in the corresponding I,, concentrations (TABLE 1, columns 3 & 4). In a previous report' we established that both ara-A (without coformycin) and ara-H also were three times more effective as inhibitors of viral DNA synthesis (TABLE 1) . In comparison, ara-C inhibited neither cellular nor viral DNA synthesis preferentially (p = 0.39, FIGURE 3). Examination of individual gradients showed, however, that in all experiments ara-C concentrations 5 0.2 pM inhibited cellular DNA synthesis in slight preference to viral DNA synthesis, whereas at concentrations greater than this the opposite was true (FIGURE 2). Similar experiments have been performed to evaluate the effects of PAA, ribavirin, stallimycin, and 2,3-dihydro-lH-imidazo[l,2-b]pyrazole (IMPY) . The activity of the last compound against HSV has been reported by Pelling and Shipman.'* The first three compounds all produced a greater inhibition of viral DNA synthesis than of cellular DNA synthesis. Stallimycin was approximately 3-fold more potent in this regard. However, variation in the degree of inhibition of cellular DNA synthesis observed in duplicate experiments resulted in some overlap of 95% confidence intervals ( concentrations difficult--even though cellular DNA synthesis appears to be much less sensitive to the two drugs than does viral DNA synthesis. IMPY affected the synthesis of the two DNA species in an opposite manner. This compound was 68% more potent in its inhibition of cellular DNA synthesis. The two dose-response curves used to calculate I,, concentrations were not coincident (p = 0.003, data not shown).
Calculation ofthe Seleclive Index
I n the preceding sections we have compared drug effects on total DNA synthesis and on separated cellular and viral DNA synthesis. We believe, however, that the The S1 is positive if viral DNA synthesis is inhibited preferentially and negative if uninfected cellular DNA synthesis is more strongly inhibited.
SI values were calculated for the drugs evaluated in this study from the data listed in TABLE I (columns I & 4). TABLE 2 ranks these drugs according to their SI. Ara-A plus coformycin, ara-A, ara-H, PAA, and stallimycin were positively selective whereas ara-C and ribavirin were negatively selective. § The coincidence of the two dose-response regression lines (from which the component I,, values were calcu-$To simplify descriptions, we have termed drugs that preferentially inhibit viral DNA synthesis as "positively selective" and drugs that preferentially inhibit host cell DNA synthesis as "negatively selective." 
) .
With the exception of stallimycin, the regressions were different (the parallel lines were defined by separate regressions, p 5 0.05). For example, the dashed line in FIGURE 1 for ara-C was parallel to, but separate from, the solid line in FIGURE 3. On the other hand, the pairs of dose-response lines for PAA and ribavirin were not parallel (p < 0.005) and therefore not coincident.
Eflect of Cell Propagation Method on SI
In a previous communication7 we reported that ara-A and ara-H were more selective in suspension cultures than in monolayer cultures. This was the result of a greater inhibition of viral DNA synthesis in HSV-infected cells grown in suspension culture. We speculated that the cause was a less efficient adsorption of HSV than had occurred in monolayer cultures. We now have tested this speculation by evaluating ara-H in monolayer cultures infected with HSV at a multiplicity of infection (MOI) of 1 rather than 10. The selectivity of ara-H was increased to 1.0 in monolayer cultures infected at a MOI of 1 (TABLE 3) . This was the result of an increase in the drug sensitivity of viral DNA synthesis and not of a change in the drug sensitivity of DNA synthesized in uninfected K B cells (TABLE I) .
Inhibition of HSV Replication
The effect of drugs on HSV replication in K B cells was measured by assaying in BHK-2114 cells the number of plaque-forming units of newly synthesized virus. Dose response relationships were constructed for each drug (data not shown) and com- 
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DISCUSSION
The biochemical method described herein has been used to evaluate the specifcity of drug action on host cell and viral DNA synthesis. The method is proposed not as a primary screening technique [or antiviral drugs but rather as an additional, more specific test of drugs found active in the more routine in vilro Together, information derived from both procedures could be valuable in predicting drug efficacy and toxicity in vivo. That is, positively selective drugs that are active against DNA viruses might be expected to cause less cytotoxic manifestations in vivo (e.g., depression of immune mechanisms, bone marrow, etc.) than drugs that are negatively selective. Although we have utilized only HSV Type 1 in the current study, the method should be applicable to any herpesvirus whose DNA can be separated from I n the present study we have concluded that the best measure of a drug's selectivity should be based upon a comparison of drug efects as described in our definition of the SI, namely, a comparison of the inhibition of DNA synthesis in uninfected, logarithmically growing cells to inhibition of viral DNA synthesis. This appears to best approximate the in vivo situation where a drug will exert its antiviral effect based on inhibition of viral DNA synthesis in the infected cell and will cause toxic effects on uninfected proliferating cells at sites that may be remote to the viral infection. We rejected the more simple comparison of drug effects on total DNA synthesis in uninfected and HSV-infected cells as the sole measure of selectivity because host cell DNA synthesis contributes to the latter measurement. The exact nature of cellular DNA in HSV-infected cells and the control of its synthesis is somewhat unclear, and, as judged from the variability of inhibition (see confidence intervals, TABLE I , column 3), drug effects are more difficult to quantitate. That is not to say, however, that effects on host cell DNA synthesis in infected cells should be ignored. As is evident in FIGURE 2, the selectivity expressed by ara-A plus coformycin is most readily discerned by comparison with cellular DNA synthesis within the infected cells.
Our choice of the 50% inhibitory concentration as the basis for comparing drug effects may complicate the interpretation of selectivity in some instances. If doseresponse curves are parallel the I,,, concentration is simple to determine and will yield the same SI as would the 10% or 90% inhibitory concentrations. However, if dose-response curves are not parallel, as was the case with ribavirin and PAA, then the choice of any inhibitory concentration as the basis of comparing the two curves may be improper. I n the latter case comparisons based on the slopes of the lines might be more valid, Fortunately, in the case of PAA and ribavirin the interpretation was the same on either basis o f comparison.
The additional possibility that we did not measure drug action on DNA synthesis must be considered. I n this and our prior articles6~' the incorporation of [3H]dThd into acid-precipitable material has been equated with DNA synthesis. We have not ruled out the possibility, however, that the noted selective effects were the result of differential changes in the specific activity of [SH]dThd nucleotides, which might accompany drug treatment or HSV-infection. In fact, it has been known for a number of years that HSV-infection increases dThd nucleotide pools in mammalian cell^.'^*^^ However, for this increase to influence the reported selectivities (both positive and negative) pool sizes in uninfected and HSV-infected cells also would have to change independently with changes in drug concentration. Although we have no data for most of the drugs studied, we have observed that 120 pM ara-A did not alter the labeling of dThd nucleotides in B-mix K-44/6 cells (unpublished observation).
Moreover, to attribute the preferential inhibition of viral or cellular DNA synthesis within the infected cell to drug-related pool size changes requires that viral and cellular DNA be synthesized from separate dThd nucleotide pools in the nuclei of HSV-infected cells. Also these pools would have to change independently with drug concentration changes. In addition, the close correspondence between inhibition of viral DNA synthesis and inhibition of HSV replication (TABLE 4) argues that, for the drugs tested, inhibition of [3H]dThd incorporation into viral DNA is a fair measure of inhibition of viral DNA synthesis. Nonetheless, experimental determination of nucleotide pool sizes or specific activity of [3H]dThd incorporated into DNA will be required to totally resolve the issue.
If drug-induced pool size changes do alter the SI, the alteration most likely would be with those drugs whose selectivity arose from differential inhibition of total DNA synthesis-such as ara-C (FIGURE 1) or ribavirin. In the case of ara-C, however, it is interesting that our results are in accord with those of Kaplan and B e n -P~r a t '~* '~ who also observed a preferential inhibition of DNA synthesis in uninfected rabbit kidney cells compared to HSV-or PRV-(pseudorabies virus)-infected cells. These investigators concluded that ara-C was not a specific antiviral agent. The accord between the two sets of data is particularly noteworthy because our experiments were performed with HSV, which increases dThd nucleotide pool ~i z e , '~. '~ and theirs with PRV, which does
In contrast, Sidwell and H~ffman~concluded that ara-C possessed a high degree of antiherpes activity having a VR greater than that of ara-A (1.3 compared with 1.1). Our results with ribavirin also differ with those of Huffman and coworkers.20 The antiviral activity of the drug appears lower in our KB cells = 123 pM, TABLE 4) than in theirs [minimum inhibitory concentration (MIC) = 4.1 pM], but direct comparisons between ls0 values and MIC values may be misleading. Of more concern is the potent inhibition of DNA synthesis we observed with ribavirin in uninfected KB cells (Iso = 1.9 pM) compared with a relative lack of cytotoxicity measured microscopically by Huffman et a/.20 Although drug-induced changes in dThd nucleotide pool sizes or use of logarithmically growing cultures of KB cells (compared with Sidwell and associates' use of stationary may account for the noted differences, we have no data to support either possibility. On the other hand, the observation that ribavirin exhibited negative selectivity when examined in the usual manner (TABLE I, The selective inhibition of viral DNA synthesis compared with cellular DNA synthesis has been noted with other inhibitors. Becker and WeinbergZ2 have reported that a concentration of 96.5 p M stallimycin completely inhibited the synthesis of viral DNA but only partially reduced the amount of cellular DNA. The effects of this drug were not as potent in the current study (TABLE I , column 4). Furthermore, we observed a progressive decrease in the bouyant density of viral and cellular DNA synthesized in the presence of increasing drug concentrations. This indicates that even though cellular DNA was synthesized, it may not have been able to function normally. Phosphonoacetic acid similarly has been shown to selectively inhibit the synthesis of HSV DNA.23 Although we did not observe the nearly total selectivity against viral DNA synthesis (TABLE 1, columns 3 & 4) noted previouslyz3 the two sets of data probably can be reconciled by Overby and associates' use of confluent cult u r e~.~~ In fact, our results agree in general with those of Overby et al. 23 and Huangz4 who found that concentrations of PAA required to totally block viral DNA synthesis also partially inhibited DNA synthesis in logarithmically growing, uninfected cells.
This observation is consistent with DNA polymerase 0 being insensitive to the drug, whereas DNA polymerase a! has equalz5 or lesserZ6 sensitivity than does HSV DNA polymerase. Schildkraut et aLZ7 have reported the selective inhibition of HSV replication by 5-bromodeoxycytidine and 5-iododeoxycytidine. The selective action appears to be dependent upon a virus-induced enzyme that catalyzed the conversion of the halogenated analogues of deoxycytidine to the corresponding nucleotides. Zinc ions also have been found to inhibit the replication of HSV.28 Inhibition appears to be a consequence of the selective blockage of viral DNA synthesis through the inhibition of HSV DNA polymerase. Prusoff and c011eagues~~ recently reported on the selective inhibition of HSV by 5'-amino-2',5'-dideoxy-5-iodouridine (AIU). Again, the high selectivity of AIU for HSV-infected cells probably is related to the specificity of a HSV-induced enzyme. I n contrast, a selective inhibition of cellular DNA synthesis in HSV-infected and Epstein-Barr virus-infected cells has been reported with cordycepin3" and with hydroxyurea.sl SUMMARY A cell culture system has been utilized to measure the effects of drugs on DNA synthesis in uninfected and HSV-(herpes simplex virus)-infected KB cells. DNA from HSV-infected cells was separated into viral and cellular components by isopycnic centrifugation in CsCl gradients. The amount of [3H]thymidine incorporated into acid-insoluble material was measured in the absence and presence of drugs. Dose-response relationships were established by linearly regressing the probit value of the percent inhibition of DNA synthesis against the logarithm of drug concentration. Fifty percent inhibitory (1s") concentrations were interpolated from the corresponding regression lines for inhibition of the following: (i) DNA synthesis is uninfected K B cells, (ii) total DNA synthesis in HSV-infected KB cells, (iii) cellular DNA synthesis in HSV-infected cells, and (iv) viral DNA synthesis in HSV-infected cells.
We have derived an index (SI, selective index) that quantifies the preferential inhibition of viral or uninfected cellular DNA synthesis. This index can be expressed as I,, concentration for DNA synthesis in uninfected cells 1," concentration for viral DNA synthesis in HSV-infected cells SI = log,,
The SI is positive if viral DNA synthesis is inhibited preferentially and negative if uninfected cellular DNA synthesis is.more strongly inhibited.
A positive SI value of 0.5 was obtained for the clinically useful antiviral drug arabinosyladenine (ara-A) and a value of 0.4 f o r its metabolite, arabinosylhypoxanthine (ara-H). Although the adenosine deaminase inhibitor coformycin greatly increased the potency of ara-A, the inhibitor did not increase the selectivity of the drug (SI = 0.3). Stallimycin (distimycin A) (SI = 0.3) and phosphonoacetic acid (SI = 0.3) were similarly effective in preferentially inhibiting the synthesis of HSV DNA. In contrast, arabinosylcytosine (ara-C) and ribavirin inhibited DNA synthesis in uninfected cells to a greater degree than viral DNA synthesis (SI = -0.5 and -1.9, respectively).
An analysis of the advantages and limitations of this experimental procedure is made and the suggestion is offered that the in vitro determination of a drug's selective index may be a valid predictor of clinical usefulness.
